Terpinen-4-ol: A Novel and Promising Therapeutic Agent for Human Gastrointestinal Cancers

Open Access

Peer-reviewed

Research Article

Shiran Shapira,

Affiliation Laboratory of Molecular Biology, The Integrated Cancer Prevention Center, Tel Aviv Sourasky Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel
⨯
Shlomo Pleban,

Affiliation EMERALD BIO-LABS LTD, Netanya, Israel
⨯
Diana Kazanov,

Affiliation Laboratory of Molecular Biology, The Integrated Cancer Prevention Center, Tel Aviv Sourasky Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel
⨯
Peter Tirosh,

Affiliation EMERALD BIO-LABS LTD, Netanya, Israel
⨯
Nadir Arber

* E-mail: nadir@tlvmc.gov.il

Affiliation Laboratory of Molecular Biology, The Integrated Cancer Prevention Center, Tel Aviv Sourasky Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel
⨯

Reader Comments (0)

Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Colorectal cancer
Is the Subject Area "Colorectal cancer" applicable to this article?

Thanks for your feedback.
Prostate cancer
Is the Subject Area "Prostate cancer" applicable to this article?

Thanks for your feedback.
Gastric cancer
Is the Subject Area "Gastric cancer" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
MTT assay
Is the Subject Area "MTT assay" applicable to this article?

Thanks for your feedback.
Enzyme assays
Is the Subject Area "Enzyme assays" applicable to this article?

Thanks for your feedback.